In The News

The Road Ahead for Biden’s FDA Nominee Robert Califf


15 Nov 2021

Stacy Cline Amin spoke to Axios about former Food and Drug Administration chief Robert Califf returning to his role.

Califf will face a Senate Health, Education, Labor, and Pensions Committee hearing on his nomination soon, though Stacy said he’s unlikely to get a floor vote by the end of the year, adding that the committee may not feel as much time pressure because [Woodcock] is “doing a good job and is generally well-liked.”

“This time has been really really hard for the agency,” Stacy said. “The staff is working around the clock. They are exhausted. I think it’s good they chose a nominee who has experience with the agency. It will be a smooth transition, likely. I think that’s important for the workforce there.”

Read the full article.



Unsolicited e-mails and information sent to Morrison & Foerster will not be considered confidential, may be disclosed to others pursuant to our Privacy Policy, may not receive a response, and do not create an attorney-client relationship with Morrison & Foerster. If you are not already a client of Morrison & Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.